News

A side effect the medical community is worried about is peripheral neuropathy – where there is damage to the nerves outside the brain and spinal cord. This results in pain, numbness or weakness, ...
Plenty folk have an asthma puffer but few seem to know how to use it. Adherium says its Hailie device is improving compliance – and lives.
Rare earth metals power modern tech and clean energy, driving global trade shifts and geopolitical tension as new materials ...
Three months after the US Sofdra launch, prescriptions have exceeded Botanix Pharmaceuticals' expectations. What are they ...
Sepideh Moafi is all set to entertain fans with a new project. The Black Bird and Class of ’09 star has officially joined ...
Biotech’s challenges roll deep on the road to innovation, from the intrinsic complexity of biology itself to regulatory ...
Atitso Charles Akpalu isn rsquo;t your average retired civil servant . With over four decades of dedicated service ...
Many modern devices – from cellphones and computers to electric vehicles and wind turbines – rely on strong magnets made from a type of minerals call ...
Dr Boreham’s Crucible: Sizing up the opportunity for ASX biotech Adherium Plenty folk have an asthma puffer but few seem to know how to use it.
Asthma sufferers are notoriously poor at taking their medicine properly. Adherium is here to help. Pic: Supplied/Stockhead Don't miss out on the headlines from Stockhead.
Botanix Pharmaceuticals (ASX:BOT) CEO Dr Howie McKibbon says investors shouldn’t rely just on management’s assertion that its anti-sweating drug Sofdra has – and we paraphrase – “the ...
Israel has engineered what might best be called bio-necro-politics: a regime in which the technologies of life and death, ...